Hjem › Post-COVID-tilstander (lang-COVID) › Florida › Tampa
Kliniske studier for Post-COVID-tilstander (lang-COVID) i Tampa, FL
4 studier for Post-COVID-tilstander (lang-COVID) søker deltakere på steder i og rundt Tampa (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
RekruttererFase 3
- New Tampa Health ( Site 3764), Tampa
- Clinical Research Trials of Florida ( Site 3703), Tampa
- Precision Research Center ( Site 3704), Tampa
A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease
RekruttererFase 3
- New Tampa Health, Tampa
- Research Bay, Inc., Tampa
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RekruttererFase 3
- Research Site, Tampa
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RekruttererFase 3
- Global Health Research Center - Tampa, Tampa
Post-COVID-tilstander (lang-COVID)-studier i andre byer
- New York City, NY15 studier
- Houston, TX13 studier
- Boston, MA13 studier
- Baltimore, MD12 studier
- Chicago, IL11 studier
- Washington, DC10 studier
- San Francisco, CA8 studier
- Durham, NC8 studier
- Atlanta, GA8 studier
- San Diego, CA7 studier
- Los Angeles, CA6 studier
- Pittsburgh, PA6 studier
Andre studier i Tampa
- Ikke-småcellet lungekreft51 studier
- Brystkreft43 studier
- Kreft (alle typer)39 studier
- Kolorektal kreft34 studier
- Akut myelogen leukemi29 studier
- Metastatisk kreft29 studier
- Lungekreft29 studier
- Pankreaskreft26 studier
- Eggstokkreft21 studier
- Melanom19 studier
- Myelodysplastiske syndromer19 studier
- Prostatakreft18 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.